0001769029-21-000002.txt : 20210323 0001769029-21-000002.hdr.sgml : 20210323 20210322175745 ACCESSION NUMBER: 0001769029-21-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210323 DATE AS OF CHANGE: 20210322 EFFECTIVENESS DATE: 20210323 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Abfero Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001769029 IRS NUMBER: 811705490 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-393097 FILM NUMBER: 21762360 BUSINESS ADDRESS: STREET 1: 405 WALTHAM STREET STREET 2: SUITE 353 CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 7812667297 MAIL ADDRESS: STREET 1: 405 WALTHAM STREET STREET 2: SUITE 353 CITY: LEXINGTON STATE: MA ZIP: 02421 D 1 primary_doc.xml X0708 D LIVE 0001769029 Abfero Pharmaceuticals, Inc. 405 WALTHAM STREET SUITE 353 LEXINGTON MA MASSACHUSETTS 02421 7812667297 DELAWARE None None Corporation true Thomas X Neenan 8-10 St. Mary's Street Boston MA MASSACHUSETTS 02215 Executive Officer Director Steven Burke 8-10 St. Mary's Street Boston MA MASSACHUSETTS 02215 Executive Officer Director Michael Penington 8-10 St. Mary's Street Boston MA MASSACHUSETTS 02215 Director Biotechnology No Revenues 06b false 2021-03-22 false true true false 50000 1000000 500000 500000 false 2 0 0 100000 true false Abfero Pharmaceuticals, Inc. Jeffrey R. Harder Jeffrey R Harder VP Administration and General Counsel 2021-03-22